Hepatoma Research
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Hepatoma Research
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig2

From:  The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review
The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review

Figure 2. Summary of the different pathways involved in the anti-HCC activity of luteolin (created with BioRender.com). ↑: increase; ↓: decrease. HCC: Hepatocellular carcinoma; SIRT1: sirtuin 1 protein; Cdk2: cyclin-dependent kinase 2; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; TGF: transforming growth factor.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties